DefenCath® (taurolidine and heparin) catheter lock solution is indicated to reduce the incidence of catheter-related bloodstream infections (CRBSI) in adult patients with kidney failure receiving chronic hemodialysis (HD) through a central venous catheter (CVC). This drug is indicated for use in a limited and specific population of patients.

Healthcare Professionals

At CorMedix, we are committed to partnering with healthcare professionals who are dedicated to improving human health and quality of life for patients. As part of that commitment, we recognize the value of collaborating with healthcare professionals and aim to further their efforts through providing grant opportunities and research collaborations.


For Medical Information Queries

For medical information or to report an adverse event or product complaint, please contact us by phone at +1 844-424-6345 or by email at





We are committed to the advancement of education for healthcare professionals to enhance patient care. All educational grants must be made for the purpose of supporting objective and balanced education that furthers improvements in science, medicine, or patient care. All requests for medical education support must align with our defined areas of strategic interest.


Complete Form






We are dedicated to improving the quality of human life and advancing medical sciences. As part of this commitment, we recognize the valuable role that our support of Investigator Initiated Research plays in fulfilling this mission. Investigator Initiated Research is observational and interventional research designed to advance scientific knowledge of disease states, patient populations, and medical treatment in alignment with our clinical and nonclinical areas of interest.


This support can be in the form of product, funding, or in some cases, both funding and product, as allowed under applicable laws and regulations. This program is open to clinicians, researchers, and institutions interested in conducting their own research.